Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Vaginal Atrophy|Postmenopausal Symptoms|Breast Cancer Female|Long-term Survivors
Interventions: DRUG: Vaginal Dehydroepiandrosterone|COMBINATION_PRODUCT: Vaginal Polycarbophil Moisturizer
Sponsor: University of Arkansas
Collaborators: AMAG Pharmaceuticals, Inc.